Healthcare -
Biotechnology - NASDAQ - US
$ 2.63
3.66 %
$ 12.6 M
Market Cap
-0.31
P/E
PHIO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PHIO - Phio Pharmaceuticals Corp.
8 K
LAST VALUE
43.74%
2 YEAR CAGR
16.12%
5 YEAR CAGR
-44.56%
10 YEAR CAGR